This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Anti-D ( antiD ) in threatened miscarriage

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • Anti-D Ig is no longer necessary in women with threatened miscarriage with a viable fetus and cessation of bleeding before 12 weeks' gestation (1)
    • "..evidence that women are sensitised after uterine bleeding in the first 12 weeks of pregnancy where the fetus is viable and the pregnancy continues is scant though there are very rare examples.. Against this background, routine administration of anti-D Ig cannot be recommended. However it may be prudent to administer anti-D Ig where bleeding is heavy or repeated or where there is associated abdominal pain particularly if these events occur as gestation approaches 12 weeks. The period of gestation should be confirmed by ultrasound..."

NICE state with respect to use of Anti-D rhesus prophylaxis in ectopic pregnancy and miscarriage (2)

  • offer anti-D rhesus prophylaxis at a dose of 250 IU (50 micrograms) to all rhesus negative women who have a surgical procedure to manage an ectopic pregnancy or a miscarriage
  • do not offer anti-D rhesus prophylaxis to women who:
    • receive solely medical management for an ectopic pregnancy or miscarriage or
    • have a threatened miscarriage or
    • have a complete miscarriage or
    • have a pregnancy of unknown location
  • do not use a Kleihauer test for quantifying feto-maternal haemorrhage

Reference:

  1. Royal College of Obstetricians and Gynaecologists. Clinical Green Top Guidelines (22) - Use of Anti-D Immunoglobulin for Rh Prophylaxis - Revised May 2002.
  2. NICE (September 2023).Ectopic pregnancy and miscarriage: diagnosis and initial management

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.